Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses (Journal of Lipid Research, 2022)

(untitled) - Ibi, D; Boot, M; Dollé, MET; Jukema, JW; Rosendaal, FR; Christodoulides, C; Neville, MJ; Koivula, R; Rensen, PCN; Karpe, F; Noordam, R; Willems van Dijk, K